Atlas Trials

Clinical Study of Safety and Tolerability of Melphalan Hydrochloride for R/R MM

Clinical trial NCT05438394 · UNKNOWN

Trial details

NCT number
NCT05438394
Sponsor
Peking University People's Hospital
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2022-10-13
Primary completion
2023-12-31
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.